CSL (ASX: CSL; USOTC: CSLLY) has unveiled four-year results from its pivotal HOPE-B study, demonstrating the long-term ...
The researchers found that the intermittent fasting group showed significant decreases in serum malondialdehyde levels and ...
Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online Jan. 18 in Scientific Reports.
All 16 patients were unresponsive to primary high-dose corticosteroid therapy for acute GVHD. Ten patients received antithymocyte globulin, and 15 received daclizumab concomitantly with infliximab.
Certepetide plus chemotherapy showed signs of efficacy but failed to improve progression-free survival in metastatic PDAC in the ASCEND trial. Data from the phase 2 ASCEND trial (NCT05042128) showed ...
Elevated liver enzymes can occur for many reasons. Most often, elevated liver enzymes are temporary and resolve on their own without treatment. Occasionally, elevated liver enzymes require additional ...
Investing.com -- Barclays downgraded Ford Motor (NYSE:F) to Equal Weight from Overweight in a note Wednesday, citing concerns about elevated volume headwinds and uncertainty surrounding the ...
The 52-week high for the stock is $99.62. Short interest on CELH stands at 12.7% of the total float. The Seeking Alpha Quant Rating on CELH has been flashing Strong Sell or Sell since June 27 of ...
You might also like: A Nintendo Switch 2 public demo event is coming to Canada soon Netflix has officially axed its cheapest ad-free plan in Canada The company’s last price increase in Canada was in ...
First approval in the U.S. for Daiichi Sankyo and AstraZeneca’s DATROWAY based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death versus chemotherapy Second ...
Treatment response was evaluated in terms of virological effectiveness and alanine transaminase normalization rates. Virological response (VR), ALT normalization rates, renal function markers ...